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Abstract
: The use of opioid analgesics to control pain after median sternotomy in cardiac surgical patients
is worldwide accepted and established. However, opioids have a wide range of possible side effects,
concerning prolonged extubation time, gastrointestinal tract dyskinesia and urinary tract disorders
mostly retention. All these may lead to a prolonged ICU stay or overall hospitalization time
increase.
Objective:  To determine whether a continuous subcutaneous regional anesthetic infusion
delivered directly to the sternotomy site would result in decreased levels of postoperative pain and
opioid requirements in cardiac surgical patients undergoing median sternotomy.
Method: The continuous subcutaneous infusion (OnQ Painbuster system) was applied in 37
patients. 3 patients were exempted due to prolonged ICU stay. 29 patients underwent CABG, 5
had AVR, 1 MVR and modified Maze, 1 patient had a 3-valve repair due to endocarditis and another
one had reconstruction of the left ventricle. Requirements of opioid analgesics were recorded for
96 hours after operation. Pain was assessed using the visual analog scale and the total postoperative
hospital length of stay was also measured.
Results:  The postoperative pain was significantly diminished (0 – 3 at VAS). The mean
postoperative length of stay was 5,8 days, rather improved compared to the average stay of 6,7
days.
Conclusion: Continuous subcutaneous infusion of ropivacaine directly at the median sternotomy
significantly diminishes postoperative pain and the need for opioid analgesic use. Moreover, it
seems to reduce overall postoperative length of stay for all cardiac surgical patients.
Background
One of the majors concerns of any surgical patient enter-
ing an ICU is pain. In cardiac surgical patients, pain is
mostly due to median sternotomy (or sometimes thora-
cotomy) and it seems to be higher on the first two days
which is the usual length of stay at the cardiac ICU [1].
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Traditional teaching suggests that pain after median ster-
notomy is alleviated best with parenteral opioid-based
analgesics. Non-steroid anti-inflammatory agents
(NSAIDS) or other types of analgesics failed to show sig-
nificant benefit over opioids in cardiac surgical patients.
However, opioid analgesics are well known for their
major and sometimes dreadful side effects, especially on
cardiac surgical patients who should be discharged from
ICU on a fast tract protocol [1-3]. Opioid adverse effects
such as respiratory depression, nausea, vomiting,
decreased gastro-intestinal (GI) motility or even ileus and
urinary retention can prolong the length of stay of
patients on the cardiac surgical ICU or at the ward. This
undesired prolongation of length of hospital stay because
of opioid side effects is well known to surgeons, anesthe-
siologists and nursing personnel caring for the cardiac sur-
gical patient sustaining a median sternotomy [2,4].
There are several methods to deliver opioid analgesia,
mostly patient controlled or nurse controlled. None of
them seem to be free of opioid adverse effects, though.
This is especially true in cardiac surgical patients after
median sternotomy. These patients need to remain calm
and relaxed. Most important, they should be able to take
easy, deep breaths to avoid atelectasis and get out of bed
as soon as possible. All these cannot happen when they
are in pain [5].
Multimodal analgesia, combining the use of nerve block-
ade followed by intravenous analgesia in the usual man-
ner has been tried but failed to show any particular benefit
in clinical trials [2,4,6]. The need to find a way to safely
and easily reduce pain in cardiac surgical patients sustain-
ing medial sternotomy is more than obvious. More that
10,000 median sternotomies for coronary arterial by-pass
grafting (CABG), valve or aortic operations are performed
annually in Greece. Improved pain control and subse-
quent improved patient outcomes would provide a sub-
stantial national health care benefit. Therefore, we
designed this clinical study to examine the hypothesis that
the continuous subcutaneous infusion of a local anes-
thetic non-opioid solution at the median sternotomy site
would produce sufficient pain control so as to completely
or at least partly avoid the use of intravenous opioid anal-
gesics in cardiac surgical patients. The overall hospital
length of stay was also examined.
Materials and methods
The study population included 76 adult patients. They all
underwent median sternotomy. The various cardiac oper-
ations included CABG (43 patients), AVR (17 patients),
MVR (9 patients), MVR and ablation for atrial fibrillation
(AF) (5 patients), triple valve operation for endocarditis
(1 patient) and reconstruction of an aneurysm of the left
ventricle – Dor operation (1 patient). The exclusion crite-
ria were prolonged ICU stay more than three days, failure
of the patients to comprehend and cooperate with the vis-
ual analog pain scale (VAS) preoperatively and failure to
understand and sign the appropriate informed consent.
The demographic characteristics of the patients and oper-
ative management are summarized on table 1.
Each of the patients was given a thorough explanation of
the study by one of the surgeons in our department. Then,
the patient was introduced to the VAS. This was our choice
to try to calculate and rate the pain derived from the
median sternotomy. Patients were taught to use the colors
on the scale and match them with the severity of pain. The
scale ranged from 0 (no pain) to 10 (maximum pain
imaginable). Study participants were informed that they
could use intravenous drugs to alleviate severe postopera-
tive pain but they should do so only when the pain was
really disturbing and severe. This study did not incur any
additional cost to the patient. The cost of the cardiac oper-
ation was fully covered by the patients' insurance organi-
zations, as usual.
Cardiac operations were performed in the usual manner
and at the end of the operation the sternum was reapprox-
imated with heavy wire. Exactly above the sternum and
before closing the subcutaneous fascia, two especially
designed catheters were placed on the sternum, through
the skin using matching introduction hollow needles and
sheaths. These slim catheters were equipped with multiple
small side openings towards their end. The drastic length
of each catheter, the part with the holes was 12,5 cm (4,92
in). They were placed right above the wired sternum and
stabilized by sticking the tip of the catheter under the first
wire. This method of stabilization was developed by our
group with intend to avoid placing extra absorbable
sutures to stabilize the catheters. It also helped in removal
of them. We did not experience any catheter breaks on
removal, as noted by other groups [1]. The catheters were
connected to a pressurized elastomeric pump equipped
with a standard flow regulator which allowed for delivery
of the anesthetic mixture at a fixed rate of 4 ml/h. the vol-
Table 1: Demographic characteristics and operative management 
of study group
Ropivacaine study group
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ume of the pump was 400 ml. The pump was filled with a
mixture containing 300 ml ropivacaine (2 mg/ml) plus
100 ml ropivacaine (7,5 mg/ml). The catheters were not
stitched to the patients' skin to avoid patients' discomfort.
Instead they were stabilized with an adhesive tape on the
skin, next to the mediastinal drains. The whole specially
designed system which was used was the OnQ Painbuster
pain relief system provided by CORMED Hellas.
The choice of the proper anesthetic to use was between
two long acting local anesthetic agents, namely ropi-
vacaine and bupivacaine. Literature suggests though that
ropivacaine sustains significantly less cardiotoxicity than
bupivacaine [1,3]. For that reason, ropivacaine was our
local anesthetic of choice.
The catheters were removed after four days. Nurses at the
ICU and the ward were supplied with a form for each
patient. In that form they filled the number of times they
used intravenous opioids to comfort the patients during
the first four postoperative days and the dosage given.
They also marked the time passed to extubation, the time
until the first bowel movement and the time needed for
the patient to sit on a char and to ambulate. After patients'
extubation and until day four, a surgeon of our depart-
ment asked them twice daily to mark on the VAS the sever-
ity of the sternotomy pain. Patients also were asked of the
occurrence of pruritus, nausea and vomiting by the same
surgeon and all answers were noted. The time intervals
from arriving at the ICU to discharge from ICU and dis-
charge from the hospital were assessed as usual according
to the department's standardized protocol for all patients
undergoing cardiac surgery.
Results
A total of 79 adult patients were enrolled in this study.
However, three patients were excluded because they
required prolonged intubation, more than two days. The
postoperative course was uncomplicated for the rest 76
patients. During the first four postoperative days, the
patients who received continuous subcutaneous anes-
thetic infusion experienced far less sternotomy pain than
the rest of the departments' patients who were treated
with opioid infusions in the usual way. Of the 76 patients,
57 did not need any supplemental opioid iv infusions and
the rest needed only small infrequent doses, compared
with the rest of the patients. All cases of significant pain
complaints were checked with continuous ECG monitor-
ing and troponine tests to rule out ischemic causes.
All 76 patients cooperated very well with the VAS and the
results were excellent. The VAS rates were between 0 and 3
with a mean overall VAS score of 1,4. Moreover, the sub-
jective pain estimation on behalf of the patients was
equally good. (table 2) None of the patients complained
of a postoperative sternotomy pain severe enough to dis-
turb easy breathing and movement in any way. Each
patient's primary nurse, along with filling the above men-
tioned form, also noted whether he/she believed that the
patient had usual pain levels or improved pain control.
The results were that 64% of patients didn't experience
any significant pain at all, 29% experienced improved
pain compared with the other cardiac surgical patients
and only 7% of the patients enrolled in this study experi-
enced the "usual" pain.
There was no drug toxicity identified in any of the 76
patients neither were any concerns about it during the
overall postoperative course. There were no wound infec-
tions or wound healing complications in any of the
patients in the study. Also, there were no complications
related to placement or removal of the catheters. None of
the patients experienced any discomfort at all related to
the catheters or the catheter removal.
The postoperative length of hospital stay for the patients
received catheter delivered analgesia was reduced. There
was a difference in extubation time between the ropi-
vacaine group and patients treated for pain with opioids
(control group). A difference was also noted in the time
needed for the first bowel movement. It was also obvious
that patients enrolled in this study spent less time in the
ICU, were able to get sit on the chair and get out of the bed
sooner than the control group. (table 3). The mean length
of stay (LOS) for the patients enrolled in this study was
5,8 days, with a range of 4 to 9 days. The usual mean LOS
for cardiac surgical patients in our department is 6,7 days.
All the above measured parameters are summarized in the
table 2.
The difference in the mean LOS is statically significant and
expresses the quicker discharge from the ICU and the hos-
pital for the patients who received continuous subcutane-
ous catheter derived analgesia for their median
sternotomy incisions.
Of note, none of the 76 patients had any pulmonary com-
plications.
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Discussion
The effective management of pain is of paramount impor-
tance to both patients and doctors. This is particularly true
to surgical patients. The most important source of postop-
erative pain is the surgical incision. There is increasing evi-
dence that improved postoperative pain management,
especially after major operations, has significant physio-
logic benefits. Surgical patients who can breathe easily
and mobilize shortly after the operation enjoy much
lesser respiratory complications, namely atelectasis and
infections. On the other hand, mortality and morbidity
after major operations are related at least partly to the
pathophysiologic response to the major injury sustained
by the surgical incision and to postoperative complica-
tions related to pain. Postoperative pain and the subse-
quent use of opioid analgesics to alleviate it is a major
drawback to the uncomplicated postoperative recovery.
Postoperative pain after major procedures is mostly dealt
with by ICU personnel and alleviated with use of opioid
analgesics. This is mostly true for thoracic and abdominal
operations during which huge muscle masses are incised
or split apart [5]. However, opioid use can increase
adverse effects and contribute to delays in postoperative
recovery. Opioids can cause respiratory depression or
even apnea, both of which lead to delays in weaning from
the ventilator. Also, they can lead to nausea and vomiting
and to subsequent aspiration chemical pneumonia. More-
over, ileus or constipation can prolong just by themselves
the ICU stay of the patient. Jaundice is another dreadful
side effect, caused by biliary spasm. Finally, opioids can
cause ureteral or cystic spasm and lead to urinary reten-
tion. These adverse effects of opioid use mostly affect the
immediate postoperative course of the surgical patient. It
is obvious that the use of opioid-sparing analgesic tech-
niques that can improve postoperative pain control with
less or even without opioid medication might facilitate
the recovery process and rehabilitation of surgical
patients. However, no opioid-sparing analgesic regimen
has been effective so far [2,4,6].
In cardiac surgery, most operations are performed
through a median sternotomy. The current trend in post-
operative management of cardiac patients is directed to
early extubation and to fast-tracking of patients out of the
ICU and subsequently the hospital. However, there have
been no advances in methods to improve the control of
pain after median sternotomy. Pain in cardiac ICUs is still
treated with iv opioid analgesics. These agents are usually
sufficient enough to relieve patients from postoperative
pain and dismobility. However, opioids do have well
known and above mentioned adverse effects. This can be
a major setback to the well renounced fast-tracking post-
operative cardiac surgical protocol. Cardiac surgical
patients need to remain calm, breath with ease and get out
of bed as soon as possible. The cardiac ICU personnel are
fully aware of that and use opioid analgesics in a free man-
ner to promote it. However, their side effects can under-
mine this fast-tracking protocol and prolong ICU stay of
cardiac surgical patients.
Several alternative methods have been proposed instead
of the traditional opioid use. NSAIDS were implied alone
or combined with opioid administration but failed to
show any particular benefit over opioids alone [6]. The so
called combined treatment, implicating parasternal
blockade together with intravenous opioids did not gain
popularity mostly because of the short duration of act of
the parasternal block [2,4,5]. On the other hand, there is
a resurgence of interest in the use of continuous adminis-
tration of local anaesthetics directly on the surgical wound
in several surgical specialties. Regional infusion of ropi-
vacaine has been successful in elective cesarean delivery as
well as in colon and rectal surgery and after orthopaedic
operations [7,8]. However, this method of analgesia has
been mostly successful after thoracic operations per-
formed with standard posterolateral thoracotomy. This
highly painful incision has been successfully alleviated
with single shots of continuous infusion of ropivacaine or
bupivacaine directly in the intrapleural space. All these
studies and clinical trials have proven the efficacy and
safety of this method of regional analgesia and most of all
the success in freedom from iv opioids.
Considering all the above facts we decided to proceed to a
clinical trial implying direct and continuous infusion of a
long acting topical anaesthetic agent directly on the ster-
notomy wound after cardiac operations. The nature of dif-
ferent cardiac procedures was not of importance because
the postoperative pain is currently indifferently treated
with opioids and the method of continuous anaesthetic
infusion was examined to be efficient in every cardiac pro-
cedure. The severity of the operation and the preoperative
condition of the patients were not considered drawbacks
because this method has been already thoroughly tested
in other surgical specialties as mentioned and proved gen-
erally safe.
Table 3: Recovery times after surgery
Ropivacaine group Control group
Time to extubation(h) 6 (+/-2) 9 (+/-2)
First bowel movement(h) 4,3 7,4
ICU stay(h) 11,7 15,4
Time to sit on chair(h) 25,2 27,1
Time to walk(h) 38,4 54,7
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The results were complimentary of the method of contin-
uous infusion of local anaesthetics. This study clearly
demonstrates that the use of ropivacaine as a long acting
local anaesthetic delivered directly in the subcutaneous
tissue of the median sternotomy incision can reduce or
even negate the use of intravenous opioids after major car-
diac procedures. The use of the VAS as an objective man-
ner of testing postoperative pain proved the efficacy of
this method. Moreover, nurses reported minimal opioid
use. In fact most patients did not need any opioids at all.
The relief of pain reported by nurses in charge of each
patient was also significant. The patients implied in this
study were free of disabling pain and the adverse effects
resulting from it. All of them were able to easily breathe
their way out of the ventilator and off the bed. None
developed respiratory complications of any manner.
The subcutaneous catheters proved easy to use and
remove. There were no infections in all patients enrolled
in the study. The catheters did not cause discomfort in any
way. Surgeons were able to perform wound dressing
changes easily while the catheters were in place and the
nursing personnel did not have any difficulty dealing with
the elastomeric pump or the device as a whole. In fact, the
pump was filled in the operation room and followed the
patient thereafter as a unit until it was removed on day
four. Thus there was no addition to the usual patient care
on behalf of the nursing personnel.
Finally, the LOS was considerably reduced. This result
matches the fast-tracking protocol widely accepted by car-
diac surgeons and anaesthetists for cardiac surgical
patients and clearly points the way traditionally opioid
pain alleviation adversely affects this protocol.
In conclusion, the continuous infusion of ropivacaine
directly on the sternotomy wound with specially designed
subcutaneous catheters has been proved effective in
reducing postoperative pain in cardiac operations of most
kinds. This method also improved many patient outcome
variables especially time to ambulation and LOS and
most of all patient satisfaction with their pain manage-
ment. This non-opioid analgesic method facilitates the
fast-tracking protocol after open heart surgery.
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